SCHEMBL1727751

SCHEMBL1727751

NC(=O)c1cccc(NC(=O)c2ccc(S(=O)(=O)C3CCc4ccccc4N3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.43
PARP10 Q53GL7 3/20 0.43
PARP15 Q460N3 2/20 0.43
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLB P06746 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PLAU P00749 1/20 0.40
KCNK3 O14649 2/20 0.40
KCNK9 Q9NPC2 2/20 0.40
MAPK14 Q16539 2/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1727700 0.89 KMT2A (0.50) MEN1KMT2AALDH1A1TSHRHTT
SCHEMBL1728248 0.88 ADORA3 (0.54) MEN1KMT2AALDH1A1L3MBTL1KCNK3
SCHEMBL1727750 0.88 KMT2A (0.47) MEN1KMT2AALDH1A1TSHRHTT
SCHEMBL1726839 0.86 RAB9A (0.55) MEN1KMT2AALDH1A1RXFP1KCNK3
SCHEMBL1727843 0.85 PHGDH (0.42) MEN1KMT2AKCNK3KCNK9MAPK14
SCHEMBL1727755 0.83 NAMPT (0.53) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL1727677 0.82 NAMPT (0.55) MEN1KMT2AALDH1A1MAPT
SCHEMBL1728014 0.81 NPC1 (0.45) MEN1KMT2AHTTL3MBTL1POLB
SCHEMBL1727825 0.80 RAB9A (0.52) MEN1KMT2AALDH1A1KCNK9MAPT
SCHEMBL1727761 0.79 KMT2A (0.41) MEN1KMT2AALDH1A1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2403499-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL Stemsynergy Therapeutics, Inc (US) 2012-01-11 EP disclosed
WO-2010101964-A2 METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL STEMSYNERGY THERAPEUTICS, INC (US) 2010-09-10 WO disclosed